Trials / Completed
CompletedNCT04366297
Intravascular Access of COVID-19 Patient Under Personal Protective Equipment
Intraosseous Versus Intravenous Access During COVID-19 Patients Performed by Paramedics Wearing Level C Personal Protective Equipment. A Multi-center Prospective Randomized Crossover Single-blinded Simulation Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Lazarski University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intravenous access | obtaining intravascular access using a standard intravenous cannula |
| DEVICE | Intraosseous access | obtaining intravascular access using a ready intravenous NIO needle set |
Timeline
- Start date
- 2020-01-12
- Primary completion
- 2020-02-25
- Completion
- 2020-02-25
- First posted
- 2020-04-28
- Last updated
- 2020-04-28
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04366297. Inclusion in this directory is not an endorsement.